Variables | Total(n = 272) | Survivor(n = 199) | Death(n = 73) | p_value |
---|---|---|---|---|
Basic Information | Â | Â | Â | Â |
 Age(years) | 46.36 ± 17.10 | 44.66 ± 16.47 | 51.01 ± 18.02 | 0.006 |
 Gender(Male, n, %) | 161(59.2%) | 120(60.3%) | 41(56.2%) | 0.538 |
 Diabetes(n, %) | 57(21.0%) | 44(22.1%) | 13(17.8%) | 0.440 |
 Hypertension(n, %) | 75(27.6%) | 52(26.1%) | 23(31.5%) | 0.379 |
 CKD1(n, %) | 91(33.5%) | 66(33.2%) | 25(34.2%) | 0.867 |
 CKD2(n, %) | 44(16.2%) | 35(17.6%) | 9(12.3%) | 0.297 |
 CKD3(n, %) | 92(33.8%) | 65(32.7%) | 27(37.0%) | 0.504 |
 CKD4(n, %) | 29(10.7%) | 21(10.6%) | 8(11.0%) | 0.923 |
 CKD5(n, %) | 16(5.9%) | 12(6.0%) | 4(5.5%) | 0.864 |
Laboratory Parameters | Â | Â | Â | Â |
 WBC (*109) | 9.1(5.57–13.44) | 9.3(5.47–13.94) | 8.7(5.83–12.79) | 0.483 |
 NEUT (%) | 88.0(80.60-92.85) | 87.2(80.5–91.9) | 89.4(80.45–93.60) | 0.262 |
 Lym (*109) | 0.54(0.25-1.00) | 0.59(0.318–1.11) | 0.4(0.18–0.90) | 0.012 |
 HGB (g/L) | 101 ± 26 | 101 ± 25 | 101 ± 29 | 0.928 |
 PLT (*109) | 152(88–219) | 154(91–223) | 139(66–201) | 0.201 |
 CRP (mg/L) | 158.3 ± 87.9 | 150.1 ± 87.1 | 180.7 ± 86.7 | 0.011 |
 Alb(g/L) | 24.6 ± 6.8 | 24.7 ± 7.0 | 24.4 ± 6.3 | 0.748 |
 Glb(g/L) | 24.0 ± 7.8 | 24.5 ± 7.6 | 22.5 ± 8.1 | 0.062 |
 PCT(µg/L) | 6.05(0.97–37.72) | 5.34(0.82–39.27) | 7.01(1.53–34.26) | 0.227 |
 IL6(ng/L) | 137.60(43.52–445.30) | 123.40(41.03–352.70) | 243.5(63.51–854.10) | 0.005 |
 FIB (g/L) | 4.71(3.58–5.88) | 4.83(3.80–6.12) | 4.54(3.04–5.20) | 0.008 |
 ALT(U/L) | 36(24–67) | 33(23–57) | 45(24–85) | 0.004 |
 AST(U/L) | 37(25–65) | 34(22–52) | 57(35–89) | 0.000 |
 TBIL(µmol/L) | 7.2(3.4–12.9) | 6.6(3.3–11.1) | 9.6(3.6–41.9) | 0.001 |
 LDH (U/L) | 763(449–1270) | 717(432–1033) | 1112(622–2036) | 0.000 |
 proBNP(pmol/L) | 784(159–2733) | 749(100–2174) | 1901(421–3970) | 0.003 |
 CD4 (cells/µl) | 139(70–313) | 160(93–351) | 76(28–213) | 0.000 |
 CD8 (cells/µl) | 140(62–262) | 157(80–310) | 80(35–179) | 0.000 |
 PL(n, %) | 76(27.9%) | 19(9.5%) | 57(78.1%) | 0.000 |
Organ Support | Â | Â | Â | Â |
 CRRT(n, %) | 150(55.1%) | 86(43.2%) | 64(87.7%) | 0.000 |
 Vasoactive Drugs (n, %) | 93(34.2%) | 32(16.1%) | 61(83.6%) | 0.000 |
 Ventilation(n, %) | 108(39.7%) | 45(22.6%) | 63(86.3%) | 0.000 |
Infection Status | Â | Â | Â | Â |
 BloodInfect(n, %) | 172(63.2%) | 132(66.3%) | 40(54.8%) | 0.080 |
 LungInfect(n, %) | 145(53.3%) | 89(44.7%) | 56(76.7%) | 0.000 |
 OtherInfect(n, %) | 39(14.3%) | 33(16.6%) | 6(8.2%) | 0.081 |
 G+ (n, %) | 50(18.4%) | 39(19.6%) | 11(15.1%) | 0.393 |
 G− (n, %) | 150(55.1%) | 106(53.3%) | 44(60.3%) | 0.303 |
 Fungal (n, %) | 110(40.4%) | 69(34.7%) | 41(56.2%) | 0.001 |
 Virus(n, %) | 63(23.2%) | 37(18.6%) | 26(35.6%) | 0.003 |
Disease severity score | Â | Â | Â | Â |
 GCS | 14(8–15) | 14(14–15) | 6(6–10) | 0.000 |
 SOFA | 8 ± 5 | 6 ± 4 | 13 ± 4 | 0.000 |
 qPBS | 3 ± 3 | 2 ± 2 | 6 ± 3 | 0.000 |